ACC SUP PLUG
Boston Scientific · Decision date Sep 16, 2025
What did the FDA decide?
FDA records P910077/S196 as a supplement to PMA P910077, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 16, 2025.
FDA approval order statement
for removing an Ethelyne Oxide (EO) chemical indicator dot applied to the outside of sterile packaging pre-sterilization and evaluated visually post-sterilization
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 16, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P910077/S196
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific
- Product code
- LWS
- Decision code
- OK30
- Decision date
- Sep 16, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable cardioverter defibrillator (non-CRT).
- Applicant
- Boston Scientific
- Product code
- LWS
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P910077/S196 received
Application receipt date recorded by FDA.
P910077/S196 · FDA decision
30-Day Notice
P910077/S197 · Related supplement
Lead Port Plug Model 6996
P910077/S199 · Related supplement
DF-1 Plug (Model 6996)
P910077/S198 · Related supplement
LATITUDE NXT Remote Patient Management System; LATITUDE NXT System Server Software Model 6460
Timeline entries are records held by MedtechLedger for P910077. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P910077
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Lead Port Plug Model 6996P910077/S197 | Boston Scientific | PMA supplement | Apr 10, 2026 | FDA |
DF-1 Plug (Model 6996)P910077/S199 | Boston Scientific | PMA supplement | May 15, 2026 | FDA |
| Boston Scientific | PMA supplement | Jul 1, 2026 | FDA |
Explore the linked device profile
Other records with product code LWS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Nov 5, 2026 | FDA | |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Nov 4, 2026 | FDA | |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S967 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 29, 2026 | FDA |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 4100 Hamline Ave. N, St Paul, MN, 55112
Sources and methodology
- Original FDA record: P910077/S196
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



